Market Analysis

Which U.S. segments carry enough size and growth to justify an Invivoscribe offering. United States, 2025–2036, $ Million.

Market size 2025

$XX.XM

the total U.S. market

Placeholder

Market size 2036

$XX.XM

the total U.S. market

Placeholder

CAGR

XX.X%

Placeholder

Incremental opportunity

$XX.XM

Placeholder

Market forecast

the total U.S. market · $ Million

Data available with full BIS Research access.
Y axis:
$ Million
X axis:
Year (2025–2036)

Segment composition by service offering

2025 and 2036 shares

Incremental-opportunity waterfall

Contribution to growth by service offering, 2025–2036

Data available with full BIS Research access.
  • End-to-end Clinical WGS Services
  • Component-based Services
Y axis:
$ Million